PRE vs. HBIO, SEER, AKYA, BNGO, RPID, AXDX, OMIC, TLIS, ASTC, and PRPO
Should you be buying Prenetics Global stock or one of its competitors? The main competitors of Prenetics Global include Harvard Bioscience (HBIO), Seer (SEER), Akoya Biosciences (AKYA), Bionano Genomics (BNGO), Rapid Micro Biosystems (RPID), Accelerate Diagnostics (AXDX), Singular Genomics Systems (OMIC), Talis Biomedical (TLIS), Astrotech (ASTC), and Precipio (PRPO). These companies are all part of the "analytical instruments" industry.
Harvard Bioscience (NASDAQ:HBIO) and Prenetics Global (NASDAQ:PRE) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, community ranking, profitability, valuation and risk.
Prenetics Global has a consensus price target of $9.00, indicating a potential upside of 47.54%. Given Harvard Bioscience's higher possible upside, analysts plainly believe Prenetics Global is more favorable than Harvard Bioscience.
Harvard Bioscience has higher revenue and earnings than Prenetics Global. Harvard Bioscience is trading at a lower price-to-earnings ratio than Prenetics Global, indicating that it is currently the more affordable of the two stocks.
80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 25.0% of Prenetics Global shares are owned by institutional investors. 9.0% of Harvard Bioscience shares are owned by insiders. Comparatively, 7.8% of Prenetics Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Harvard Bioscience has a net margin of -8.18% compared to Harvard Bioscience's net margin of -193.60%. Prenetics Global's return on equity of 0.26% beat Harvard Bioscience's return on equity.
Harvard Bioscience has a beta of 1.25, indicating that its share price is 25% more volatile than the S&P 500. Comparatively, Prenetics Global has a beta of -0.16, indicating that its share price is 116% less volatile than the S&P 500.
Harvard Bioscience received 363 more outperform votes than Prenetics Global when rated by MarketBeat users. However, 83.33% of users gave Prenetics Global an outperform vote while only 72.02% of users gave Harvard Bioscience an outperform vote.
In the previous week, Harvard Bioscience had 4 more articles in the media than Prenetics Global. MarketBeat recorded 6 mentions for Harvard Bioscience and 2 mentions for Prenetics Global. Prenetics Global's average media sentiment score of 1.52 beat Harvard Bioscience's score of 1.27 indicating that Harvard Bioscience is being referred to more favorably in the media.
Summary
Harvard Bioscience beats Prenetics Global on 12 of the 17 factors compared between the two stocks.
Get Prenetics Global News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Prenetics Global Competitors List
Related Companies and Tools
